finasteride has been researched along with Breast Cancer, Male in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bolin, K; Brasso, K; Emneus, M; Ersbøll, AK; Green, A; Iversen, P; Kjaerulff, TM; Pukkala, E; Thygesen, LC | 1 |
| Bolin, K; Brasso, K; Emneus, M; Ersbøll, AK; Green, A; Iversen, P; Meijer, M; Pukkala, E; Stavem, K; Thygesen, LC | 1 |
| Bolin, K; Brasso, K; Emneus, M; Ersbøll, AK; Green, A; Iversen, P; Kjærulff, TM; Pukkala, E; Thygesen, LC | 1 |
| Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Hartzema, AG | 1 |
| Bosch, JL; de Boer, A; De Bruin, ML; Duijnhoven, RG; Hoes, AW; Souverein, PC; Straus, SM | 1 |
| Ellis, RJ; Lee, SC | 1 |
| Farinas, E; Wysowski, DK | 1 |
| Fourcroy, JL; Green, L; Wysowski, DK | 1 |
9 other study(ies) available for finasteride and Breast Cancer, Male
| Article | Year |
|---|---|
Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Aged, 80 and over; Breast Neoplasms, Male; Case-Control Studies; Confounding Factors, Epidemiologic; Data Analysis; Denmark; Finasteride; Finland; Humans; Male; Middle Aged; Registries; Sweden; Testicular Diseases | 2020 |
Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Breast Neoplasms, Male; Child; Child, Preschool; Finasteride; Follow-Up Studies; Humans; Incidence; Infant; Infant, Newborn; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Registries; Scandinavian and Nordic Countries; Young Adult | 2018 |
Finasteride Use and Risk of Male Breast Cancer: A Case-Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Breast Neoplasms, Male; Case-Control Studies; Denmark; Finasteride; Finland; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Prognosis; Registries; Risk Factors; Sweden | 2019 |
Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Aged, 80 and over; Azasteroids; Breast Neoplasms, Male; Dutasteride; Finasteride; Humans; Male; Middle Aged | 2013 |
Long-term use of 5α-reductase inhibitors and the risk of male breast cancer.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Breast Neoplasms, Male; Case-Control Studies; Dutasteride; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Risk Factors; United Kingdom | 2014 |
Finasteride: male breast cancer.
Topics: 5-alpha Reductase Inhibitors; Breast Neoplasms, Male; Finasteride; Humans; Male | 2010 |
Male breast cancer during finasteride therapy.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Breast Neoplasms, Male; Carcinoma, Ductal; Doxazosin; Drug Labeling; Enzyme Inhibitors; Finasteride; Gynecomastia; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; United States | 2004 |
Finasteride in benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Breast Neoplasms, Male; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; United States | 2004 |
Gynecomastia and breast cancer during finasteride therapy.
Topics: Breast Neoplasms, Male; Finasteride; Gynecomastia; Humans; Male; Prostatic Hyperplasia | 1996 |